EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Defense DEF

Pharmacy issues related to the annual defense authorization and implementation of the 2017 NDAA.

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); Labor, Dept of (DOL); Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Internal Revenue Service (IRS); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); SENATE

Taxation/Internal Revenue Code TAX

Implementation of tax provisions of the ACA, including the insurer tax. Tax reform policies.

Contacted: Health & Human Services, Dept of (HHS); SENATE; Government Accountability Office (GAO); Congressional Budget Office (CBO); White House Office; Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); Office of Personnel Management (OPM); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Internal Revenue Service (IRS); Labor, Dept of (DOL); Food & Drug Administration (FDA)

Health Issues HCR

Regulatory policies related to the health reform law, including drug benefits and disclosure. Implementation of HITECH. Prescription drug affordability issues. Reforms to Medicaid and Exchange markets.

Contacted: White House Office; Health Resources & Services Administration (HRSA); Federal Trade Commission (FTC); SENATE; Internal Revenue Service (IRS); Office of Personnel Management (OPM); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Congressional Budget Office (CBO); Food & Drug Administration (FDA); Government Accountability Office (GAO)

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing the Part D coverage gap, direct negotiation of prescription drug prices. Implementation of opioid abuse "lock in" provisions from CARA. Medicare Part B reforms. S. 637; HR 1920; HR 1939.

Contacted: Government Accountability Office (GAO); Internal Revenue Service (IRS); White House Office; SENATE; Executive Office of the President (EOP); Office of Personnel Management (OPM); Health Resources & Services Administration (HRSA); Congressional Budget Office (CBO); Medicare Payment Advisory Commission (MedPAC); Federal Trade Commission (FTC); Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1939 (115th), S. 637 (115th), H.R. 1920 (115th)

Pharmacy PHA

Design and coverage of pharmacy benefits in Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, EPCS, PBM disclosure, MLR, and specialty pharmacy tiering. Implementation of biosimilars pathway from BPCIA. Policies placing restrictions on pharmacy benefit design. Issues relating to prescription drug affordability. REMS reform. Prescription drug user fee reauthorization. HR 1854; S. 788; HR 2025.

Contacted: SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Labor, Dept of (DOL); Government Accountability Office (GAO); Office of Personnel Management (OPM); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); Internal Revenue Service (IRS); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); White House Office; Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2025 (115th), H.R. 1854 (115th), S. 788 (115th)